000			02121 a2200649 4500
005			20250517193628.0
264		0	_c20180309
008			201803s 0 0 eng d
022			_a1432-0584
024	7		_a10.1007/s00277-017-3224-2 _2doi
040			_aNLM _beng _cNLM
100	1		_aBen Lakhal, Raihane
245	0	0	_aChronic myeloid leukemia patients in Tunisia: epidemiology and outcome in the imatinib era (a multicentric experience). _h[electronic resource]
260			_bAnnals of hematology _cApr 2018
300			_a597-604 p. _bdigital
500			_aPublication Type: Comparative Study; Journal Article; Multicenter Study
650	0	4	_aAdolescent
650	0	4	_aAdult
650	0	4	_aAged
650	0	4	_aAged, 80 and over
650	0	4	_aAntineoplastic Agents _xadverse effects
650	0	4	_aChild
650	0	4	_aChild, Preschool
650	0	4	_aFemale
650	0	4	_aFollow-Up Studies
650	0	4	_aHumans
650	0	4	_aImatinib Mesylate _xadverse effects
650	0	4	_aLeukemia, Myeloid, Accelerated Phase _xdiagnosis
650	0	4	_aLeukemia, Myeloid, Chronic-Phase _xdiagnosis
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aPractice Patterns, Physicians'
650	0	4	_aPrognosis
650	0	4	_aProtein Kinase Inhibitors _xadverse effects
650	0	4	_aRetrospective Studies
650	0	4	_aSplenomegaly _xetiology
650	0	4	_aSurvival Analysis
650	0	4	_aTumor Burden _xdrug effects
650	0	4	_aTunisia _xepidemiology
650	0	4	_aYoung Adult
700	1		_aGhedira, Hela
700	1		_aBellaaj, Hatem
700	1		_aBen Youssef, Yosra
700	1		_aMenif, Samia
700	1		_aManai, Zeineb
700	1		_aBedoui, Manel
700	1		_aLakhal, Amel
700	1		_aM'Sadek, Fehmi
700	1		_aElloumi, Moez
700	1		_aKhélif, Abderrahmane
700	1		_aBen Romdhane, Neila
700	1		_aLaatiri, Mohamed Adnène
700	1		_aBen Othmen, Tarek
700	1		_aMeddeb, Balkis
773	0		_tAnnals of hematology _gvol. 97 _gno. 4 _gp. 597-604
856	4	0	_uhttps://doi.org/10.1007/s00277-017-3224-2 _zAvailable from publisher's website
999			_c27952384 _d27952384